These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 25662347)

  • 1. Regulation of Treg-associated CD39 in multiple sclerosis and effects of corticotherapy during relapse.
    Muls NG; Dang HA; Sindic CJ; van Pesch V
    Mult Scler; 2015 Oct; 21(12):1533-45. PubMed ID: 25662347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fingolimod increases CD39-expressing regulatory T cells in multiple sclerosis patients.
    Muls N; Dang HA; Sindic CJ; van Pesch V
    PLoS One; 2014; 9(11):e113025. PubMed ID: 25411844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral CD39-expressing T regulatory cells are increased and associated with relapsing-remitting multiple sclerosis in relapsing patients.
    Álvarez-Sánchez N; Cruz-Chamorro I; Díaz-Sánchez M; Lardone PJ; Guerrero JM; Carrillo-Vico A
    Sci Rep; 2019 Feb; 9(1):2302. PubMed ID: 30783191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression.
    Borsellino G; Kleinewietfeld M; Di Mitri D; Sternjak A; Diamantini A; Giometto R; Höpner S; Centonze D; Bernardi G; Dell'Acqua ML; Rossini PM; Battistini L; Rötzschke O; Falk K
    Blood; 2007 Aug; 110(4):1225-32. PubMed ID: 17449799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.
    Fletcher JM; Lonergan R; Costelloe L; Kinsella K; Moran B; O'Farrelly C; Tubridy N; Mills KH
    J Immunol; 2009 Dec; 183(11):7602-10. PubMed ID: 19917691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypical analysis of ectoenzymes CD39/CD73 and adenosine receptor 2A in CD4
    Han L; Sugiyama H; Zhang Q; Yan K; Fang X; McCormick TS; Cooper KD; Huang Q
    Australas J Dermatol; 2018 Feb; 59(1):e31-e38. PubMed ID: 28295154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD39/CD73 and the imbalance of Th17 cells and regulatory T cells in allergic asthma.
    Wang LL; Tang HP; Shi GC; Wan HY; Tang W; Hou XX; Pan LN; Shi BY; Tao LQ
    Mol Med Rep; 2013 Nov; 8(5):1432-8. PubMed ID: 24065069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD39+ regulatory T cells attenuate allergic airway inflammation.
    Li P; Gao Y; Cao J; Wang W; Chen Y; Zhang G; Robson SC; Wu Y; Yang J
    Clin Exp Allergy; 2015 Jun; 45(6):1126-37. PubMed ID: 25728362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysfunctional CD39(POS) regulatory T cells and aberrant control of T-helper type 17 cells in autoimmune hepatitis.
    Grant CR; Liberal R; Holder BS; Cardone J; Ma Y; Robson SC; Mieli-Vergani G; Vergani D; Longhi MS
    Hepatology; 2014 Mar; 59(3):1007-15. PubMed ID: 23787765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compromised CD4+ CD25(high) regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level.
    Venken K; Hellings N; Thewissen M; Somers V; Hensen K; Rummens JL; Medaer R; Hupperts R; Stinissen P
    Immunology; 2008 Jan; 123(1):79-89. PubMed ID: 17897326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated regulatory T-cells attenuate myocardial ischaemia/reperfusion injury through a CD39-dependent mechanism.
    Xia N; Jiao J; Tang TT; Lv BJ; Lu YZ; Wang KJ; Zhu ZF; Mao XB; Nie SF; Wang Q; Tu X; Xiao H; Liao YH; Shi GP; Cheng X
    Clin Sci (Lond); 2015 May; 128(10):679-93. PubMed ID: 25558978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Target tissue ectoenzyme CD39/CD73-expressing Foxp3+ regulatory T cells in patients with psoriasis.
    Zhang HY; Yan KX; Huang Q; Ma Y; Fang X; Han L
    Clin Exp Dermatol; 2015 Mar; 40(2):182-91. PubMed ID: 25284153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression of CD39 on regulatory T cells is genetically driven and further upregulated at sites of inflammation.
    Rissiek A; Baumann I; Cuapio A; Mautner A; Kolster M; Arck PC; Dodge-Khatami A; Mittrücker HW; Koch-Nolte F; Haag F; Tolosa E
    J Autoimmun; 2015 Apr; 58():12-20. PubMed ID: 25640206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced Numbers and Impaired Function of Regulatory T Cells in Peripheral Blood of Ischemic Stroke Patients.
    Ruhnau J; Schulze J; von Sarnowski B; Heinrich M; Langner S; Pötschke C; Wilden A; Kessler C; Bröker BM; Vogelgesang A; Dressel A
    Mediators Inflamm; 2016; 2016():2974605. PubMed ID: 27073295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Th17 expansion in MS patients is counterbalanced by an expanded CD39+ regulatory T cell population during remission but not during relapse.
    Peelen E; Damoiseaux J; Smolders J; Knippenberg S; Menheere P; Tervaert JW; Hupperts R; Thewissen M
    J Neuroimmunol; 2011 Dec; 240-241():97-103. PubMed ID: 22035960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating dendritic cells subsets and regulatory T-cells at multiple sclerosis relapse: differential short-term changes on corticosteroids therapy.
    Navarro J; Aristimuño C; Sánchez-Ramón S; Vigil D; Martínez-Ginés ML; Fernández-Cruz E; de Andrés C
    J Neuroimmunol; 2006 Jul; 176(1-2):153-61. PubMed ID: 16698092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ex vivo expanded regulatory T cells CD4
    Lifshitz GV; Zhdanov DD; Lokhonina AV; Eliseeva DD; Lyssuck EY; Zavalishin IA; Bykovskaia SN
    Autoimmunity; 2016 Sep; 49(6):388-396. PubMed ID: 27424664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD39 expression on Treg and Th17 cells is associated with metabolic factors in patients with type 2 diabetes.
    Cortez-Espinosa N; Cortés-Garcia JD; Martínez-Leija E; Rodríguez-Rivera JG; Barajas-López C; González-Amaro R; Portales-Pérez DP
    Hum Immunol; 2015 Sep; 76(9):622-30. PubMed ID: 26386144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New regulatory CD19(+)CD25(+) B-cell subset in clinically isolated syndrome and multiple sclerosis relapse. Changes after glucocorticoids.
    de Andrés C; Tejera-Alhambra M; Alonso B; Valor L; Teijeiro R; Ramos-Medina R; Mateos D; Faure F; Sánchez-Ramón S
    J Neuroimmunol; 2014 May; 270(1-2):37-44. PubMed ID: 24662004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Phenotypical and functional characteristic of FoxP3(+);CD39(+); regulatory T cells in humans].
    Huang HH; Wang SY; Wang HF; Fu JL; Han P; Wang FS
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Jun; 26(6):536-8. PubMed ID: 20487644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.